Hurley Ariel's Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Mar 8, 2022
- Accession no.
- 0001415889-22-002754
- Filed
- Mar 8, 2022
- Trade date
- Mar 3-7, 2022
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $60.3K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hurley ArielCIK 0001769740 | Officer (PRINCIPAL ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Common Stock | SSaleDisposed | −761 | $60.27 | −$45,865.47 | 12,211 | Direct | |
| Mar 7, 2022 | Common Stock | SSaleDisposed | −256 | $56.19F2 | −$14,384.64 | 11,955 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $56.18 to $57.07 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.